IFF Achieves Reported $6B Sales in H1 with Scent Segment Up 5%
The Company anticipates that its sales for the entire year of 2023 will fall within the range of $11.3 billion […]
Dr. Plant with 4000 Stores Plans to IPO
In 2020, Dr. Plant opened online sales in Singapore on Amazon.com and Shopee.com. By the end of 2022, Dr. Plant
Intercos Net Sales Reach €488 Million in H1 with Double-Digit Growth in China
Despite the Chinese market not showing tangible signs of recovery from 2022, the region witnessed excellent performances. Notably, group sales
Chinese Hyaluronic-acid-focused IMEiK Net Profit Expected to Rise 70% YOY in H1 Reaching RMB 1Bn
During the reporting period, the company continued to adhere to the marketing model of “direct sales, supplemented by distribution” to
Symrise Unveils H1 Financial Report with €2.4Bn
The sales in the Scent & Care of Symrise recorded 886 million euros ($968.4 million) in the first half of
Beiersdorf Sales Achieves €4.9Bn in H1 with NIVEA Up 18.4%
The consumer business segment achieves organic sales by 14.9%, with nominal sales rising by 12.9% to €4.1 billion ($4.5 billion).
Chinese Cosmetics Group Chicmax Expects 28% More Than RMB1.6Bn Revenue in H1
The total revenue of Chicmax was about RMB 1.5527 billion ($215.9 million) to RMB 1.6159 billion ($224.7 million), with a
Chinese Cosmetic Brand Proya Achieves Revenue of around RMB3.545Bn in H1
After preliminary accounting, from January to June 2023, Proya realized total operating income of about 3.545 billion yuan ($493.3 million),
First Financial Report of DSM-Firmenich after the merger Shows a 5% Decline in Sales
The company predicts that its pro forma basis Adjusted EBITDA for FY 2023 will be between €1.8-1.9 billion, which is
ESG is Becoming a Standard for Chinese Beauty Companies
For many years, the cosmetics industry has been questioned by environmentalists. With concerns about the potential health risks of using
